GlaxoSmithKline agrees to sell Lucozade and Ribena to Suntory for GBP1.35bn
Allen & Overy has advised GlaxoSmithKline (GSK) on the sale of its nutritional drinks brands Lucozade and Ribena, to Suntory Beverage and Food Ltd (Suntory), the Japanese consumer goods company, for GBP1.35bn.
It is expected that the transaction will be completed by the end of the year, subject to regulatory approvals.